Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archderm.138.3.398 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of the efficacy of treatment with clobetasol propionate or bexarotene in early-stage mycosis fungoides.
An Bras Dermatol
December 2024
Dermatology Department, Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Seyrantepe, İstanbul, Turkey.
Background: There are few studies in the literature comparing the effectiveness of topical treatments in early-stage mycosis fungoides (MF).
Objectives: It was aimed to evaluate the clinical efficacy, side effects and topical treatment compliance with bexarotene or clobetasol propionate in early-stage MF.
Methods: A total of 40 patients with stage IA-IB MF were enrolled in the study.
Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides.
Healthcare (Basel)
February 2023
Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy.
Mycosis fungoides is the most common primary cutaneous T-cell lymphoma, characterized by skin-homing CD4+ T cells derivation, indolent course, and low-grade of malignancy. Mycosis fungoides's classic type typically onsets with cutaneous erythematous patches, plaque, and tumor. In WHO-EORTC classification, folliculotropic mycosis fungoides, pagetoid reticulosis, and granulomatous slack skin are recognized as distinct variants of mycosis fungoides, because of their clinical and histological features, behavior, and /or prognosis.
View Article and Find Full Text PDFPrior Bexarotene or Phototherapy Does Not Affect Response to Chlormethine Gel: Post Hoc Analysis of a Pivotal Trial.
Acta Derm Venereol
February 2023
University of Birmingham, Birmingham, UK.
Complete remission with bexarotene gel in unilesional folliculotropic mycosis fungoides located on the scalp.
Dermatol Ther
April 2022
Faculty of Medicine, Department of Pathology, Ankara University, Ankara, Turkey.
Woringer-Kolopp (Pagetoid Reticulosis) disease successful response to bexarotene gel.
Dermatol Ther
January 2017
Department of Dermatology, University of Alabama at Birmingham, EFH 414 1530 3rd Ave., South Birmingham, Alabama.
Woringer-Kolopp (WK) is a rare subtype of cutaneous T-cell lymphoma (CTCL) with limited treatment options. Bexarotene gel is a topical retinoid used in the treatment of CTCL. This report describes three female patients (mean age 66 years) with WK disease who had an effective treatment response to bexarotene 1% gel.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!